Article
Association of HER2 codon 655 polymorphism with ovarian cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jun 2016
Watrowski Rafał, Castillo-Tong Dan Cacsire, Schuster Eva, Fischer Michael B, Speiser Paul, Zeillinger Robert
Abstract excerpt
The role of the human epidermal growth factor receptor 2 (HER2) codon 655 (Ile655Val) polymorphism in ovarian cancer is not fully understood. Two studies indicated a possible association between the Val allele and elevated risk or reduced prognosis of ovarian cancer. We investigated the HER2 codon 655 (rs1136201) polymorphism in 242 Austrian women-142 ovarian cancer patients and 100 healthy controls-by polymerase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
